华神科技：子公司拟2亿元出售参股公司股权 华神科技(000790)公告，子公司星瑞药业拟将持有的上海凌凯科技股份有限公司（简称"上海凌凯"） 5.4019%股份以2亿元转让给陆茜，本次交易完成后，星瑞药业不再持有上海凌凯股份。 招商银行：拟出资150亿元全资发起设立金融资产投资公司 招商银行(600036)公告，公司拟出资150亿元，全资发起设立金融资产投资公司。本次设立的金融资 产投资公司初始注册资本为人民币150亿元，由公司作为投资主体根据《金融资产投资公司管理办法 （试行）》，使用自有资金直接投资设立。成功设立后，本次设立的金融资产投资公司将成为公司全 资一级子公司，具体业务范围以金融监督管理机构批复为准。本次设立金融资产投资公司符合公司业 务发展需要，有助于丰富公司综合化经营牌照，完善投商行一体化经营，提升服务实体经济能力。本 次投资不会对公司的财务状况或经营成果产生重大影响。 2025.05. 08 5月8日晚间，沪深两市多家上市公司发布公告，以下是第一财经对一些重要公告的汇总，供投资者 参考。 【品大事】 金诚信：拟投资约2.31亿美元建设Alacran铜金银矿项目 金诚信(603979)公告，鉴 ...

Investment Announcements - Jincheng intends to invest approximately $231 million in the Alacran copper-gold-silver mine project, following the acquisition of a 5% stake in CMH Colombia S.A.S., which will allow it to hold a 55% stake and control the project development [3] - Huasheng Technology's subsidiary plans to sell a 5.4019% stake in Shanghai Lingkai Technology Co., Ltd. for 200 million yuan, resulting in the subsidiary no longer holding shares in the company [4] - China Merchants Bank plans to invest 15 billion yuan to establish a wholly-owned financial asset investment company, which will enhance its integrated operations and service capabilities [5] Performance Reports - Huahong's Q1 revenue reached 3.913 billion yuan, a year-on-year increase of 18.66%, while net profit dropped by 89.73% to 22.76 million yuan, indicating challenges in the semiconductor industry due to international and policy changes [7] - King Long Automobile reported a production of 4,361 buses in April, a decrease of 5.79% year-on-year, with sales of 3,611 buses, down 3.91% [8] - Zhengbang Technology's April pig sales reached 609,800 heads, with revenue of 738 million yuan, showing a significant year-on-year increase of 174.29% [9] - Sunac China achieved a contract sales amount of approximately 1.1 billion yuan in April, with a cumulative total of 11.2 billion yuan by the end of April [11] - *ST Aonong reported a pig sales volume of 132,800 heads in April, a year-on-year decrease of 14.42% [12] Major Contracts - Pinggao Electric won contracts totaling approximately 1.751 billion yuan from the State Grid, representing 14.12% of its 2024 revenue [14] - State Grid Information Technology's subsidiaries secured contracts worth 477 million yuan, positively impacting future performance [15] - Dongfang Tower won a procurement project from the State Grid worth about 100 million yuan, accounting for 2.39% of its 2024 revenue [16] - Jiaojian Co. won a construction project worth approximately 704 million yuan, with a project duration of 870 days, representing 8.43% of its 2024 revenue [17] Shareholding Changes - Ruihua Tai's shareholder plans to reduce holdings by up to 1% of the company's shares [19] - *ST Gengxing's controlling shareholder intends to increase holdings between 30 million and 60 million yuan [20] - Lexin Technology's shareholder plans to reduce holdings by up to 1.2032% of the company's shares [22] Share Buybacks - Sichuan Meifeng plans to repurchase shares worth between 50 million and 70 million yuan, with a maximum repurchase price of 10.07 yuan per share [24]

| 证券代码：688323 | 证券简称：瑞华泰 | 公告编号：2025-026 | | --- | --- | --- | | 转债代码：118018 | 转债简称：瑞科转债 | | 股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 大股东持有的基本情况 截至本公告披露日，国投高科技投资有限公司（以下简称"国投高科"）持 有深圳瑞华泰薄膜科技股份有限公司（以下简称"公司"）20,466,447 股股份， 占公司总股本的 11.3702%。以上股份为首次公开发行前取得的股份，且已于 2024 年 4 月 29 日起解除限售并上市流通。 减持计划的主要内容 国投高科拟通过集中竞价方式减持数量合计不超过 1,800,002 股（不超过公 司总股本比例 1.0000%）。本次减持计划自本公告披露之日起 15 个交易日之后的 3 个月内实施。 上述股份减持价格按市场价格确定，若减持期间公司有派息、送股、资本公 积金转增股本、配股等除权除息事项，减持计划将进行相应调整。 公司于近日收到 ...

瑞华泰公告，国投高科技投资有限公司拟通过集中竞价方式减持不超过180万股，占公司总股本的1%。 ...

| 证券代码：688323 | 证券简称：瑞华泰 | 公告编号：2025-025 | | --- | --- | --- | | 转债代码：118018 | 转债简称：瑞科转债 | | 深圳瑞华泰薄膜科技股份有限公司 关于"瑞科转债"跟踪信用评级结果的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 前次债券评级：公司主体信用等级为 A，评级展望为"稳定"，"瑞科转债" 的信用等级为 A。 本次债券评级：公司主体信用等级为 A，评级展望为"稳定"，"瑞科转债" 的信用等级为 A。 根据《上市公司证券发行注册管理办法》《上海证券交易所科创板股票上市规 则》等有关规定，深圳瑞华泰薄膜科技股份有限公司（以下简称"公司"）委托信 用评级机构中证鹏元资信评估股份有限公司（以下简称"中证鹏元"）对公司向不 特定对象发行的可转换公司债券（以下简称"瑞科转债"）进行了跟踪信用评级。 公司前次主体信用评级结果为 A，评级展望为"稳定"，"瑞科转债"的信用 等级为 A；评级机构为中证鹏元，评级时间为 2025 年 1 月 ...

Financial Performance - The company's operating revenue for Q1 2025 was ¥79,256,915.65, representing a 44.88% increase compared to ¥54,703,500.18 in the same period last year[4] - The net profit attributable to shareholders was -¥18,414,939.50, a slight increase in loss from -¥16,574,890.90 year-on-year[4] - The increase in operating revenue was primarily driven by the capacity release of the Jiaxing project, leading to higher sales volume[8] - Total revenue for Q1 2025 reached ¥79,256,915.65, a 44.8% increase from ¥54,703,500.18 in Q1 2024[18] - Net loss for Q1 2025 was ¥18,414,939.50, compared to a net loss of ¥16,574,890.90 in Q1 2024, indicating a decline in performance[20] - Operating profit for Q1 2025 was -¥17,918,872.94, slightly worse than -¥16,317,966.73 in Q1 2024[19] Cash Flow and Liquidity - The net cash flow from operating activities was ¥34,214,425.62, showing a 3.99% increase from ¥32,902,787.08 in the previous year[4] - Cash received from sales in Q1 2025 was ¥67,243,064.37, down 20.4% from ¥84,275,755.31 in Q1 2024[22] - The cash inflow from operating activities was $96,855,662.89, compared to $102,849,413.68, showing a decrease of about 6%[23] - Cash and cash equivalents decreased to RMB 141,328,906.84 from RMB 152,211,590.34, indicating a decline of about 7.5%[15] - Cash and cash equivalents at the end of the period totaled $141,328,906.84, down from $94,141,640.85, representing an increase of about 50%[24] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,566,631,061.12, a slight increase of 0.10% from ¥2,563,947,151.17 at the end of the previous year[5] - Total liabilities amounted to ¥1,641,924,855.70, compared to ¥1,620,826,006.25 in the previous period[17] - Non-current liabilities decreased to ¥1,042,230,082.70 from ¥1,135,110,825.51[17] - The company's equity attributable to shareholders was ¥924,706,205.42, down from ¥943,121,144.92[17] Research and Development - Research and development expenses totaled ¥7,467,497.03, which is a 7.33% decrease from ¥8,058,136.82 in the same period last year[4] - The ratio of R&D expenses to operating revenue decreased to 9.42%, down 5.31 percentage points from 14.73% year-on-year[5] - Research and development expenses for Q1 2025 were ¥7,467,497.03, a decrease from ¥8,058,136.82 in Q1 2024[19] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 5,535[10] - The company has not reported any significant changes in shareholder relationships or actions during the reporting period[12] - There were no significant changes in the top 10 shareholders or their participation in margin trading and securities lending activities[12] Other Financial Information - The company recognized government subsidies amounting to ¥1,088,065.33, which are closely related to its normal operations[6] - The financial statements for the quarter ended March 31, 2025, are unaudited[13] - The company has not identified any other important information regarding its operational performance during the reporting period[13] Operating Costs - Total operating costs for Q1 2025 were ¥98,661,338.20, up 37.4% from ¥71,851,557.80 in Q1 2024[18]

大信会计师事务所（特殊普通合伙） 关于深圳瑞华泰薄膜科技股份有限公司 2024 年年度报告的信息披露监管问询函的回复 大信备字[2025]第 5-00008 号 上海证券交易所科创板公司管理部： 我们接受委托，对深圳瑞华泰薄膜科技股份有限公司（以下简称"公司"或"瑞华泰"） 2024 年度财务报表进行了审计，并于 2025 年 3 月 20 日出具了标准无保留意见的审计报告 （大信审字[2025]第 5-00003 号）及标准无保留意见的内部控制审计报告（大信审字[2025] 第 5-00005 号）。在审计过程中，我们恪守独立、客观、公正的原则，严格按照《中国注 册会计师执业准则》的规定执行了审计工作。根据贵所科创板公司管理部下发的《关于深 圳瑞华泰薄膜科技股份有限公司 2024 年年度报告的信息披露监管问询函》（上证科创公函 【2025】0042 号）（以下简称"《问询函》"）所述相关事项，现作回复意见如下： 除特别说明外，本回复所有数值保留 2 位小数，若出现总数与各分项数值之和尾数不 符，为四舍五入原因所致。 一、关于问询事项的回复意见 一、关于经营业绩。公司目前量产产品主要为热控 PI 薄膜、电子 ...

深圳瑞华泰薄膜科技股份有限公 司 2022 年度向不特定对象发行可 转换公司债券 2025 年跟踪评级报 告 中鹏信评【2025】跟踪第【63】号 01 信用评级报告声明 除因本次评级事项本评级机构与评级对象构成委托关系外，本评级机构及评级从业人员与评级对象不存 在任何足以影响评级行为独立、客观、公正的关联关系。 本评级机构与评级从业人员已履行尽职调查义务，有充分理由保证所出具的评级报告遵循了真实、客观、 公正原则，但不对评级对象及其相关方提供或已正式对外公布信息的合法性、真实性、准确性和完整性 作任何保证。 本评级机构依据内部信用评级标准和工作程序对评级结果作出独立判断，不受任何组织或个人的影响。 本评级报告观点仅为本评级机构对评级对象信用状况的个体意见，不作为购买、出售、持有任何证券的 建议。本评级机构不对任何机构或个人因使用本评级报告及评级结果而导致的任何损失负责。 本次评级结果自本评级报告所注明日期起生效，有效期为被评证券的存续期。同时，本评级机构已对受 评对象的跟踪评级事项做出了明确安排，并有权在被评证券存续期间变更信用评级。本评级机构提醒报 告使用者应及时登陆本公司网站关注被评证券信用评级的变化情 ...

| | | 深圳瑞华泰薄膜科技股份有限公司关于 2024 年年度报告信息披露监管问询函的回复公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 深圳瑞华泰薄膜科技股份有限公司（以下简称"公司"或"瑞华泰"）于近 日收到上海证券交易所科创板公司管理部下发的《关于深圳瑞华泰薄膜科技股份 有限公司 2024 年年度报告的信息披露监管问询函》（上证科创公函【2025】0042 号）（以下简称"《问询函》"）。公司就《问询函》关注的相关问题逐项进行了 认真核查落实。现就有关问题具体回复如下： （除特别说明外，本回复所有数值保留 2 位小数，若出现总数与各分项数值之和尾 数不符，为四舍五入原因所致。） 一、关于经营业绩。公司目前量产产品主要为热控 PI 薄膜、电子 PI 薄膜和 电工 PI 薄膜三大系列，2024 年公司实现主营业务收入 33,616.84 万元，同比增 加 21.94%；实现归母净利润-5,727.49 万元，同比增加亏损 3,767.19 万元。2022 年至 2024 年，公司综合毛利率分别为 38.24%、2 ...

一、主要会计数据和财务指标 | 名称 | 持有数量(万股) | 占总股本比 | 增减情况 | | --- | --- | --- | --- | | | | 例(%) | (万股) | | 航科新世纪科技发展(深圳)有限公司 | 4208.31 | 23.38 | 不变 | | 国投高科技投资有限公司 | 2046.64 | 11.37 | 不变 | | 上海泰巨尧坤企业管理合伙企业(有限合伙) | 1761.66 | 9.79 | 不变 | | 中国合伙人(上海)股权投资基金管理有限公司-宁波达科睿华 创业投资合伙企业(有限合伙) | 825.63 | 4.59 | 不变 | | 全国社保基金五零三组合 | 480.00 | 2.67 | -90.00 | | 广发稳健回报混合A | 336.76 | 1.87 | -43.24 | | 徐炜群 | 289.54 | 1.61 | -8.90 | | 林茂波 | 287.65 | 1.60 | 29.55 | | 杭州泰达实业有限公司 | 210.00 | 1.17 | 不变 | | 中国科学院化学研究所 | 192.70 | 1.07 | 不变 | 三、分 ...